ELEVAI Labs, Inc. Expands International Distribution into Europe ELEVAI Labs, Inc. Expands International Distribution into Europe

Elevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products Elevai Labs Enters into Licensing Agreement with Yuva Biosciences

Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy SAN LEANDRO, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC)...

Nanomix Appoints Industry Veteran Tadd S. Lazarus, M.D., to the Board of Directors SAN LEANDRO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics,...

Nanomix Receives CE Mark for its eLab COVID-19 Rapid Point-of-Care Antigen Panel EMERYVILLE, Calif, May 20, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCBB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics,...